Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Aclipse Therapeutics
Aclipse Therapeutics and Cypress BioPharma Announce Agreement to Launch Phase 2 Study in Childhood Nephrotic Syndrome and Expand Renal Development Capabilities
Today 8:00 EDT
From
Aclipse Therapeutics
Via
Business Wire
Aclipse Therapeutics Expands Drug Development Pipeline with Signing of Exclusive, Worldwide License Agreement with Chong Kun Dang Pharmaceutical Corporation to Develop Potential Disease-Modifying Treatment for Gastroparesis
September 14, 2023
From
Aclipse Therapeutics
Via
Business Wire
Aclipse Therapeutics Announces $1.475 Million Award from the US Department of Defense
April 20, 2022
From
Aclipse Therapeutics
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.